+91 8826262086


Hyperbaric Oxygen Therapy (HBOT)

Hyperbaric Oxygen Therapy DOES help in Cerebral Palsy (CP) especially when combined with intensive Therapy, to a statistically significant degree. Our platform independent four way comparative study spread over 12 years has shown how. Now the highest Hyperbaric Body, the UHMS also recognizes our efforts. Working in Collaboration with an International Team, our statistically analyzed data has just been published in the world’s foremost and most stringent HBOT Journal: Undersea Hyperbaric Medicine Society of USA lead article, accompanied by an elaborate Editorial in it’s March 2014 issue.

HBOT at the pressures commonly used in children with Autism Spectrum Disorders (ASD) (up to 1.5 atm/100% oxygen) has been reported to improve cerebral perfusion, decrease markers of inflammation and not worsen oxidative stress markers. Most studies of HBOT in children with ASD reported improvements in several behavioral domains although many of these studies were not controlled. Although the two trials employing a control group reported conflicting results, a recent systematic review noted several important distinctions between these trials. Collectively, the reviewed studies indicate that the use of HBOT in children with ASD is associated with minimal adverse events and is well tolerated. We conclude that HBOT is a safe and potentially effective treatment for children with ASD but that further studies are warranted. Future studies would be wise to use standardized behavioral measurement tools and physiological biomarkers in a controlled study design. Targeting ASD subgroups that possess specific physiological abnormalities with HBOT may be a potentially fruitful method for determining which ASD individuals would benefit from treatment with HBOT.

  • Interpretation of the study “Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation


  • Hyperbaric Oxygen Therapy as adjunctive treatment for diabetic foot ulcers


  • Effects of Repetitive Hyperbaric Oxygen Treatment in Patients with Acute Cerebral Infarction: A Pilot Study


  • Hyperbaric oxygen (HBO) therapy as a treatment for stage-I avascular necrosis</span> of the femoral head


  • Hyperbaric Oxygen Induces Late Neuroplasticity in Post Stroke Patients Randomized, Prospective Trial


  • HBO mproves retinal blood flow and circulation It is also effective in reducing swelling and thereby the risk of developing glaucoma and cataract


‘5 patients with a history of Parkinson’s Disease (PD) were treated with Hyperbaric Oxygen Therapy (HBOT) for 1 hour at 1.5-2.0 ATA. All 5 patients reported a decrease in tremors and an improvement in general well-being

Experimental Stem Cell Therapy

1. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.

2. Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal

3. A review of current and novel therapies for idiopathic pulmonary fibrosis

Note : The regenerative intervention is experimental. Hereby we suggest that please do refer the guidelines of the Indian Council of Medical Research (http://icmr.nic.in/guidelines/NGSCR%202013.pdf) before deciding in favor of trying out Regenerative Medicine or Stem Cell Therapy.

In Muscular Dystrophy umbilical cord mesenchymal stem cells by intravenous infusion, in combination with multi-point intramuscular injection. They were followed up for 12 months after cell transplantation. Results showed that clinical symptoms significantly improved, daily living activity and muscle strength were enhanced, the sero-enzyme, electromyogram, and MRI scans showed improvement, and dystrophin was expressed in the muscle cell membrane. Hematoxylin-eosin staining of a muscle biopsy revealed that muscle fibers were well arranged, fibrous degeneration was alleviated, and fat infiltration was improved.

Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial.

USF study finds stem cell combination therapy improves traumatic brain injury outcomes

Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head.

The results from this preliminary observational pilot study suggest that umbilical cord stem cells may be a safe and promising treatment for children with cerebral palsy.

Biomedical Therapy

Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus.

Environmental Enrichment May Help Treat Autism — and Help Us All (Scientific American, 26th Aug’14)

Alternative Biomedical Treatments for Autism: How Good Is the Evidence? (Scientific American, 7th Oct’10)

Autism Diets: The First Step to Biomedical Intervention and Autism Recovery